BSTC Financial Facts
Licensing revenues: 762.35KTotal Cost and Expenses: 2.16M
See Full Income Statement
Short-term investments: 45.08M
Total stockholders' equity: 53.22M
See Full Balance Sheet
BioSpecifics Technologies Corp. (BSTC) Earnings
|
Expand Research on BSTC
Next EPS Date | N/A | EPS Growth Rate | N/A |
---|---|---|---|
Average EPS % Beat Rate | -0.2% | Revenue Growth Rate | N/A |
Average % Move 1-Wk after EPS | +0.3% | Normal Earnings Time | Before Open |
Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
---|---|---|---|---|---|---|---|---|---|---|---|
3/14/16 | Q416 | $0.36 | N/A | N/A | $6.1M | $4.6M | N/A | Details | |||
11/8/11 | Q311 | $0.04 | N/A | N/A | $1.9M | $1M | N/A | Details | |||
8/11/14 | Q214 | $0.09 | $0.12 | -$0.03 | $2.7M | $2.91M | N/A | Details | |||
3/9/12 | Q411 | $0.01 | N/A | N/A | $2.6M | $1.1M | N/A | Details | |||
11/10/14 | Q314 | $0.21 | $0.19 | +$0.02 | $4M | $4M | N/A | Details | |||
8/9/16 | Q216 | $0.37 | $0.35 | +$0.02 | $6.2M | $6.25M | N/A | Details | |||
5/10/16 | Q116 | $0.40 | $0.37 | +$0.03 | $6.6M | $6.25M | N/A | Details | |||
8/9/12 | Q212 | $0.11 | $0.07 | +$0.04 | $2.6M | $2.5M | N/A | Details |